Treace Medical Concepts, Inc. TMCI
Set alert
4.27 USD -0.16 -3.61%
At close
4.31 +0.04 +0.94%
Pre-market · Nov 3, 4:00 AM ET
4.24 Day range 4.80
1.17 52-week range 6.65
- YTD
- +74.29%
- 1 year
- -33.18%
- Open
- 4.45
- Prev close
- 4.43
- Mkt cap
- 277.70M
- Vol
- 168.69K
- Avg vol
- 285.23K
- EPS
- -0.96
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 4.24
- High
- 4.80
- Forward P/E
- -9.28
- Beta
- 0.24
- Short ratio
- 3.26
- Inst. own
- 64.11%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 6, 2024
- 50-d avg
- 6.87
- 200-d avg
- 7.45
- 1y target
- 7.96
Analyst view
Consensus: hold
Hold
Price target (mean) 7.96 +86.4% upside
Now 4.27
- Target (low)
- 7.50
- Target (mean)
- 7.96
- Target (high)
- 8.40
Ratings (0m) 6 0 buy · 6 hold · 0 sell
- Strong buy0
- Buy0
- Hold6
- Sell0
- Strong sell0
Recommendation trend
- This month 6
- 1 month ago 6
- 2 months ago 6
- 3 months ago 6
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.04032 | -0.06635 – -0.02461 | -0.10 | +59.7% | 66.95M | +7.6% | 3 |
| Next quarter | -0.30415 | -0.30415 – -0.30415 | -0.28092 | -8.3% | 52.30M | +2.3% | 1 |
| Current year | -0.93027 | -0.95637 – -0.91444 | -0.81 | -14.9% | 207.52M | +10.9% | 3 |
| Next year | -0.74251 | -0.77576 – -0.72 | -0.93027 | +20.2% | 225.05M | +8.5% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 18, 2024 | Truist Securities | Maintained | Hold | Hold |
| Nov 6, 2024 | Stifel | Maintained | Hold | Hold |
| Oct 14, 2024 | Truist Securities | Maintained | Hold | Hold |
| Aug 7, 2024 | UBS | Maintained | Neutral | Neutral |
| Aug 7, 2024 | Truist Securities | Maintained | Hold | Hold |
| Jul 16, 2024 | Truist Securities | Maintained | Hold | Hold |
| Jul 15, 2024 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| May 16, 2024 | UBS | Downgrade | Buy | Neutral |
| May 8, 2024 | Morgan Stanley | Downgrade | Overweight | Equal-Weight |
| May 8, 2024 | UBS | Maintained | Buy | Buy |
| May 8, 2024 | Truist Securities | Downgrade | Buy | Hold |
| May 8, 2024 | JP Morgan | Downgrade | Overweight | Neutral |
| May 8, 2024 | BTIG | Downgrade | Buy | Neutral |
| May 8, 2024 | Stifel | Downgrade | Buy | Hold |
| Dec 22, 2023 | Truist Securities | Maintained | Buy | Buy |
| Nov 13, 2023 | Morgan Stanley | Maintained | Overweight | Overweight |
| Nov 10, 2023 | Stifel | Maintained | Buy | Buy |
| Nov 10, 2023 | Truist Securities | Maintained | Buy | Buy |
| Oct 2, 2023 | Stifel | Reiterated | Buy | Buy |
| Sep 29, 2023 | UBS | Initiated | — | Buy |
| Sep 12, 2023 | Stephens & Co. | Reiterated | Equal-Weight | Equal-Weight |
| Aug 28, 2023 | BTIG | Maintained | Buy | Buy |
| Aug 10, 2023 | Stephens & Co. | Maintained | Equal-Weight | Equal-Weight |
| Aug 9, 2023 | Truist Securities | Maintained | Buy | Buy |
| Jun 2, 2023 | Stephens & Co. | Reiterated | Equal-Weight | Equal-Weight |
| May 1, 2023 | Truist Securities | Initiated | — | Buy |
| Apr 17, 2023 | BTIG | Maintained | — | Buy |
| Apr 11, 2023 | Stephens & Co. | Initiated | — | Equal-Weight |
| Mar 8, 2023 | Morgan Stanley | Maintained | — | Overweight |
| Oct 11, 2022 | Morgan Stanley | Maintained | — | Overweight |